Kolumne, ORE

Original-Research: OHB SE - from NuWays AG Classification of NuWays AG to OHB SE Company Name: OHB SE ISIN: DE0005936124 Reason for the research: Update Recommendation: Verkaufen from: 24.04.2024 Target price: EUR 44.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch KKR Takeover: still waiting for regulatory approval Topic: KKR's takeover of OHB's free float still awaits regulatory approval by three European countries, leading to a estimated closing of the transaction in Q2 / Q3 2024e.

24.04.2024 - 09:06:30

Original-Research: OHB SE (von NuWays AG): Verkaufen


Original-Research: OHB SE - from NuWays AG

Classification of NuWays AG to OHB SE

Company Name: OHB SE
ISIN: DE0005936124

Reason for the research: Update
Recommendation: Verkaufen
from: 24.04.2024
Target price: EUR 44.00
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Henry Wendisch

KKR Takeover: still waiting for regulatory approval
 
Topic: KKR's takeover of OHB's free float still awaits regulatory approval
by three European countries, leading to a estimated closing of the
transaction in Q2/Q3 2024e. Thereafter, a delisting and squeeze-out seems
likely.
 
FDI approval pending: Most conditions of the takeover are fulfilled,
however, the foreign direct investment (FDI) authorities of (1) Germany,
(2) Belgium and (3) Sweden still need to approve the takeover, while the
remaining seven relevant countries already gave their approval. Thereafter,
KKR plans to close the transaction and pay-out the cash compensation of EUR
44 per share for shareholders that tendered their shares. According to the
company, this could be as early as Q2/Q3 2024e.
 
Capital increase resolved: KKR seems confident in getting final FDI
approval, as it already solely subscribed the 10% capital increase at end
of last year. Hence, KKR now holds 9.9% directly and 18.7% indirectly of
OHB shares. The remaining 5.7% (free float was only 24.4%) have not been
tendered during the tender period.
 
Delisting ahead: Following final FDI approval and closing of the
transaction, KKR will directly hold 28.64% of shares and the Fuchs Family
Pool 65.35%, owning the the majority of votes. We expect the official
decision to delist OHB shortly after.
 
Squeeze-out likely: KKR and the Fuchs Family will directly hold a combined
93.99% of shares, but control 94.51% of voting rights (excl. treasury
shares w/o voting rights), only slightly below the required squeeze-out
level of 95%. Thus, we regard a squeezeout as likely, as KKR only needs to
acquire additional 0.49% of shares from existing shareholders, which will
be actively pursued by KKR.
 
FY'23 results driven by one-off: The first time at-equity reflection of
OHB's stake in Rocket Factory Augsburg (prev.: consolidated, but held as
discontinued operations) led to a positive EUR 76m EBITDA oneoff effect,
pushing FY'23 EBITDA to EUR 162m (EUR 87m EBITDA without the one-off effect).
 
In sum, OHB continues to walk the delisting road. As a result, we recommend
shareholders of the remaining free float to SELL at EUR 44.00 per share if
owning shares of a delisted company is not favourable.

You can download the research here:
http://www.more-ir.de/d/29507.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: BIKE24 Holding AG (von Montega AG): Kaufen Original-Research: BIKE24 Holding AG - von Montega AG Einstufung von Montega AG zu BIKE24 Holding AG Unternehmen: BIKE24 Holding AG ISIN: DE000A3CQ7F4 Anlass der Studie: Update Empfehlung: Kaufen seit: 03.05.2024 Kursziel: 2,80 EUR Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Tim Kruse (CFA), Nils Scharwächter BIKE24 schlägt sich wacker Die BIKE24 Holding AG hat gestern Zahlen für das erste Quartal 2024 vorgelegt, die im Rahmen unserer Erwartungen ausfielen. (Boerse, 03.05.2024 - 16:42) weiterlesen...

Original-Research: Cherry SE (von Montega AG): Halten Original-Research: Cherry SE - von Montega AG Einstufung von Montega AG zu Cherry SE Unternehmen: Cherry SE ISIN: DE000A3CRRN9 Anlass der Studie: Update Empfehlung: Halten seit: 02.05.2024 Kursziel: 2,50 EUR (zuvor: 2,10 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1 besser als erwartet - Wachstumsambitionen anspruchsvoll Cherry hat jüngst vorläufige Q1-Zahlen veröffentlicht. (Boerse, 02.05.2024 - 15:16) weiterlesen...

Original-Research: YOC AG (von Montega AG): Kaufen Original-Research: YOC AG - von Montega AG Einstufung von Montega AG zu YOC AG Unternehmen: YOC AG ISIN: DE0005932735 Anlass der Studie: Update Empfehlung: Kaufen seit: 02.05.2024 Kursziel: 22,50 EUR (zuvor: 21,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Tim Kruse (CFA), Nils Scharwächter YOC erneut mit deutlicher Outperformance des Gesamtmarkts - stetige Verbesserung der Cashflows visibel Die YOC AG hat jüngst den finalen Konzernabschluss vorgelegt, mit dem die bereits im Februar berichteten vorläufigen Zahlen bestätigt wurden. (Boerse, 02.05.2024 - 15:01) weiterlesen...

Original-Research: urban-gro, Inc (von First Berlin Equity Research GmbH): Ka... Original-Research: urban-gro, Inc - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to urban-gro, Inc Company Name: urban-gro, Inc ISIN: US91704K2024 Reason for the research: Cannabis Einstufung & Q1 Ergebnisse Recommendation: Kaufen from: 02.05.2024 Target price: $4,30 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu urban-gro, Inc. (Boerse, 02.05.2024 - 10:46) weiterlesen...

Original-Research: Marley Spoon Group SE (von NuWays AG): Kaufen Original-Research: Marley Spoon Group SE - from NuWays AG Classification of NuWays AG to Marley Spoon Group SE Company Name: Marley Spoon Group SE ISIN: LU2380748603 Reason for the research: Update Recommendation: Kaufen from: 02.05.2024 Target price: EUR 7.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Mark Schüssler Healthy Q1 results // FY'24 guidance confirmed; chg. (Boerse, 02.05.2024 - 09:02) weiterlesen...

Original-Research: MLP SE (von NuWays AG): Kaufen Original-Research: MLP SE - from NuWays AG Classification of NuWays AG to MLP SE Company Name: MLP SE ISIN: DE0006569908 Reason for the research: Update Recommendation: Kaufen from: 02.05.2024 Target price: EUR 12.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch RS Feedback: attractive value for money On Monday, we hosted a roadshow with CEO Dr. (Boerse, 02.05.2024 - 09:01) weiterlesen...